TruScreen Group Ltd. (AU:TRU) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
TruScreen Group Ltd. has announced a study showcasing its cervical cancer screening device’s superior performance compared to traditional Pap smears, with higher sensitivity and immediate results. The study highlights TruScreen’s practicality and reliability as a screening tool, indicating potential for policy adoption in countries lacking national programs. The technology’s validation could lead to expanded global healthcare market opportunities.
For further insights into AU:TRU stock, check out TipRanks’ Stock Analysis page.